Does CRISPR Therapeutics pay their employees well?

According to anonymously submitted Glassdoor reviews, CRISPR Therapeutics employees rate their compensation and benefits as 3.2 out of 5. Find out more about salaries and benefits at CRISPR Therapeutics. This rating has been stable over the past 12 months.

How satisfied are employees working at CRISPR Therapeutics?

46% of CRISPR Therapeutics employees would recommend working there to a friend based on Glassdoor reviews . Employees also rated CRISPR Therapeutics 2.8 out of 5 for work life balance, 3.0 for culture and values and 2.9 for career opportunities.

What are the top reviewed jobs at CRISPR Therapeutics?

Research Associate (12) , Research Associate II (5) , Research Scientist (5) , Senior Research Associate (5) , Associate Director (4) , Director (4) , Senior Scientist (4) , Scientist (3) , Anonymous (2)

What are the pros of working at CRISPR Therapeutics according to real employee reviews?

"great people to work with" ((in 15 reviews)); "Benefits are good and lunch is subsidized." ((in 11 reviews)); "Good culture and good work life balance" ((in 3 reviews))

What are the cons of working at CRISPR Therapeutics according to real employee reviews?

"Changes in senior leadership and related re" ((in 9 reviews)); "No work life balance" ((in 6 reviews)); "less pay compared to other." ((in 3 reviews)); "Salary is just average but stock options are great." ((in 3 reviews))

What are employees saying about CRISPR Therapeutics layoffs in 2026?

Explore Glassdoor’s employee reviews to understand what current and former employees are saying about CRISPR Therapeutics layoffs and their outlook for job security at CRISPR Therapeutics in 2026.

What are the top reviewed CRISPR Therapeutics locations?

Boston , Cambridge , San Francisco , Framingham , Marlborough , Norwood

Skip to content Skip to footer

Notifications

CRISPR Therapeutics

CRISPR Therapeutics reviews

3.2

46% would recommend to a friend

(88 total reviews)

Samarth Kulkarni

36% approve of CEO

39% positive business outlook

Ratings by category

3.2

Diversity & inclusion

3.2

Compensation and benefits

3.0

Culture & values

2.9

Career opportunities

2.8

Work/Life balance

2.5

Senior management

CRISPR Therapeutics has an employee rating of 3.2 out of 5 stars, based on 88 company reviews on Glassdoor which indicates that most employees have a good working experience there. The CRISPR Therapeutics employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).

Ratings by demographic groups

Race / Ethnicity

Gender

Sexual orientation

Disability

Parent or family caregiver

Veteran status

Reviews by job title

88 reviews

5.0

Jan 20, 2022

Great employer

Anonymous employee

Recommend

CEO approval

Business Outlook

Pros

Wonderful culture, benefits and atmosphere

Cons

I do not have any cons

4.0

Jan 14, 2022

Engineer Review

Anonymous employee

Recommend

CEO approval

Business Outlook

Pros

Lots of growth and leadership opportunities (if you want them). Flexible work hours

Cons

Lack of transparency between upper management and lower levels.

5.0

Dec 22, 2021

Great company!

Associate director

Recommend

CEO approval

Business Outlook

Pros

Innovative and scalable platform that can help to develop transformative therapeutics.

Cons

Need to work overtime occasionally.

Viewing 76 - 78 of 88 Reviews

Jobs at CRISPR Therapeutics

Senior Scientist, Oligonucleotide

Senior Specialist, Site Supply Chain Planning

Senior Manager, Drug Safety

Research Associate II, CRISPR-X - LNP

CRISPR Therapeutics reviews FAQs

Reviews CRISPR Therapeutics reviews

CRISPR Therapeutics

CRISPR Therapeutics reviews

Ratings by category

Ratings by demographic groups

Reviews by job title

Great employer

Engineer Review

Great company!

Jobs at CRISPR Therapeutics

CRISPR Therapeutics reviews FAQs

Want the inside scoop on your own company?

Bowls

Followed companies

Job searches

CRISPR Therapeutics reviews FAQs

Jobs at CRISPR Therapeutics